Representative Kevin Hern disclosed the sale of his entire position in UnitedHealth Group ($UNH), worth between $250,001 and $500,000, according to a newly filed Periodic Transaction Report, following congressional testimony this week by UnitedHealth’s chief executive and other healthcare leaders.
- The filing shows a sale of UnitedHealth common stock on December 23, 2025, with notification made on December 24, 2025.
- The transaction was reported as “sell to close” and attributed to a subholding of the Hern Family Revocable Trust.
- Hern represents Oklahoma’s 1st District and serves on the House Ways and Means Subcommittee on Health.
- The disclosure follows a House Energy and Commerce Subcommittee on Health hearing focused on health insurance affordability.
- UnitedHealth CEO Stephen Hemsley testified alongside executives from CVS Health, Elevance Health, and Cigna.
- Earlier this week, UnitedHealth said it plans to rebate profits from its Affordable Care Act exchange plans in 2026.
Relevant Companies
- UnitedHealth Group ($UNH) – Subject of the disclosed stock sale and recent congressional testimony on health costs and ACA-related policies.
Editor’s Note: This is a developing story. This article may be updated as more details become available.
